Co-Diagnostics (CODX) Tops Q1 EPS by 4c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $610 thousand versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• MSCI acquires First Street for $120M to expand climate risk data
• Morgan Stanley Starts OGE Energy (OGE) at Equalweight